Eltrombopag+hATG+CsA vs. hATG+CsA in Children With Severe AA

Clinical trial NCT03413306 · UNKNOWN

Trial details

NCT number: NCT03413306
Sponsor: Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Acquired Aplastic Anemia

Start date: 2016-12-10
Primary completion: 2022-10-20
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.